Histone deacetylase inhibitor application is lethal to many cancer types. To screen for the therapeutic potential of HDIs it is necessary to analyze their ability to target and kill cancer cells in vivo. Here, we describe the xenografting of (germ cell) cancer cell lines into the flank of nude mice and the subsequent intravenous application of HDIs.
CITATION STYLE
Nettersheim, D., Jostes, S., & Schorle, H. (2017). Xenografting of cancer cell lines for in vivo screening of the therapeutic potential of HDAC inhibitors. In Methods in Molecular Biology (Vol. 1510, pp. 211–215). Humana Press Inc. https://doi.org/10.1007/978-1-4939-6527-4_15
Mendeley helps you to discover research relevant for your work.